C
CourageAS is a biotherapeutics company focused on developing innovative genome editing therapies for rare diseases. The company specifically targets Angelman syndrome by combining cutting-edge science with dedicated patient advocacy. Their mission is to transform the lives of individuals impacted by this genetic disorder through advanced therapeutic solutions.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- CourageAS is a biotherapeutics company focused on developing innovative genome editing therapies for rare diseases. The company specifically targets Angelman syndrome, aiming to transform the lives of affected individuals. This venture combines advanced science and technology to create potential therapeutic solutions.